Diabetes complications

Serum Lipidomics Profiling Identify Novel Biomarkers of Distal Symmetrical Polyneuropathy in Type 1 Diabetes

Diabetes Obes MetabPublished Biomarker discovery and validation study

Authors' conclusion

We identified a reproducible lipidomic signature discriminating DSPN in type 1 diabetes. Painful DSPN was characterized by reduced unsaturated PC/PE and increased sphingolipids, offering new insight into disease pathophysiology.

Study context

Population
Individuals with T1D with and without distal symmetrical polyneuropathy (DSPN) and non-diabetic controls (discovery cohort); independent validation cohort of 99 individuals with T1D with established DSPN statusplus validation cohort n=99
Participants
109 / 44 / 50
Comparison
T1D with DSPN vs T1D without DSPN vs non-diabetic controls
  • T1D with DSPNn = 109
  • T1D without DSPNn = 44
  • Non-diabetic controlsn = 50reference
Outcome
Lipidomic biomarkers of DSPN
Methodological detailsuntargeted serum liquid chromatography-mass spectrometry lipidomics, independent validation cohort
  • Untargeted serum liquid chromatography-mass spectrometry lipidomics
  • Independent validation cohort

Performance

As reported in the abstract

Lipid species identified in the discovery cohort
543
Lipids associated with DSPN
14
Lipids with a clear pattern across non-diabetic, T1D without and with DSPN: Cer(d42:1), PC(36:4), LPC(16:0), LPE(18:1), PE(36:2), PE(O-40:5) or PE(P-40:4)
6
Lipids with the same directional changes in the validation cohort (of 6)
3
AUC for detecting DSPN, model of six lipids + HbA1c, diastolic blood pressure and age, discovery cohort
0.83 (95% CI, 0.76-0.91)
AUC for detecting DSPN, same model, validation cohort
0.81 (95% CI, 0.73-0.90)
AUC improvement by DeLong's test, discovery and validation cohorts (not significant)
p = 0.086 and 0.089
AUC improvement combined by Fisher's method (significant)
χ2 = 9.7, p = 0.045

Further findings

Lipid species differing significantly between painful and painless DSPN
22

Original publication

Serum Lipidomics Profiling Identify Novel Biomarkers of Distal Symmetrical Polyneuropathy in Type 1 Diabetes. Diabetes Obes Metab. Published 1 September 2026. doi:10.1111/dom.71257

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.